Australia’s Unique Device Identification Framework

Australia, through the Therapeutic Goods Administration (TGA), is implementing a national UDI framework as part of broader medical device reforms. At the centre of this is the Australian UDI Database (AusUDID) — a centralised platform for storing device information.

Sponsors are responsible for submitting and maintaining accurate data in the system, helping create a consistent and reliable source of device information. 

UDI stands for Unique Device Identification and is a system that assigns a unique code to each medical device which includes In Vitro Diagnostics (IVD), enabling the device to be identified and tracked throughout its lifecycle.

A sponsor refers to the entity responsible for supplying a medical device to the Australian market.

This may be:

• A local representative of an overseas manufacturer
• An importer or distributor supplying devices within Australia

Sponsors act as the accountable party for regulatory compliance, including UDI requirements.

Each UDI is made up of two key components:

• Device Identifier (DI): identifies the device model

• Production Identifier (PI): includes production details such as serial number, batch number, or expiry date

Together, these elements enable precise identification and tracking of individual devices.

Implementation will follow a phased approach. Higher-risk devices are expected to comply earlier, followed by lower-risk products.

image source from Qserve Group

UDI supports greater visibility across the product lifecycle. This allows companies to improve traceability and respond more efficiently to potential safety issues. One example could be managing recalls more quickly, which in turn reduces risk and improves response times.

From an operational perspective, UDI can provide consistent identification of devices, helping organizations better manage inventory, track usage, and optimize ordering processes. Additionally, the availability of device data will support stronger analytics and help organizations make more informed decisions.

 Companies should begin reviewing their product data, packaging, labelling, and internal systems to ensure readiness for UDI. Although implementation is phased, preparation takes time. Taking the time now to assess your packaging and how it can play a more significant role in the compliance of UDI requirements will help companies in the long run avoid disruption and reduce compliance risks. Especially when it comes to data accuracy and system integration. As more regulations and requirements like UDIs are implemented in the medical device industry, we will likely see packaging play a larger role in product traceability across a device’s lifecycle. And ultimately, supporting positive patient outcomes and a more efficient healthcare system.